News Focus
News Focus
Followers 40
Posts 8552
Boards Moderated 5
Alias Born 09/06/2014

Re: 3331 post# 335776

Monday, 12/02/2024 7:45:21 AM

Monday, December 02, 2024 7:45:21 AM

Post# of 345746
Testimonial from a stock pumper is not evidence.

There are numerous studies verifying Actipatch effectiveness and superiority to other pain management products.

"Superiority?" Cite ONE such study.

There are also studies that show Actipatch to be ineffective. Dr. Ilfeld's recent opioid study is one. Here it is:

https://clinicaltrials.gov/study/NCT05399355?tab=results

Here's another study that shows ActiPatch to be ineffective:

https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-022-06810-y

And finally: "#2 on the breakout board" doesn't prove effectiveness or superiority. A large audience on IH for a stock that is mired at a PPS of .0003 proves that the IH community is gawking at a train wreck but not buying the stock.